THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE

Bibliográfalaš dieđut
Váldodahkkit:	Aronson, J, Grahamesmith, D, Hallis, K, White, N
Materiálatiipa:	Journal article
Almmustuhtton:	1982

Geahča maid

THE DISPOSITION OF ORAL RUBIDIUM CHLORIDE IN ESSENTIAL-HYPERTENSION
Dahkki: Boon, N, et al.
Almmustuhtton: (1982)

A method for the study of cation transport in vivo: effects of digoxin administration and of chronic renal failure on the disposition of an oral load of rubidium chloride.
Dahkki: Boon, N, et al.
Almmustuhtton: (1984)

EVIDENCE THAT CATION-TRANSPORT INVIVO IS INHIBITED BY SHORT-TERM BUT NOT LONG-TERM DIGOXIN THERAPY
Dahkki: Boon, N, et al.
Almmustuhtton: (1984)

INVIVO EVIDENCE OF REDUCED CATION-TRANSPORT IN CHRONIC-RENAL-FAILURE
Dahkki: Boon, N, et al.
Almmustuhtton: (1983)

THE EFFECTS ON SALBUTAMOL ON INVIVO CATION-TRANSPORT
Dahkki: Wood, A, et al.
Almmustuhtton: (1988)

THE EFFECT OF LITHIUM ON CATION-TRANSPORT INVIVO AND INVITRO IN HEALTHY-VOLUNTEERS
Dahkki: Wood, A, et al.
Almmustuhtton: (1987)

ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM
Dahkki: Pugh, S, et al.
Almmustuhtton: (1982)

EVIDENCE FOR INCREASED INVIVO NA+/K+-ATPASE ACTIVITY IN SKELETAL-MUSCLE OF SPONTANEOUSLY HYPERTENSIVE RATS
Dahkki: Syme, P, et al.
Almmustuhtton: (1990)

EVIDENCE FOR INCREASED INVIVO NA+/H+ ANTIPORTER ACTIVITY IN SKELETAL-MUSCLE OF SPONTANEOUSLY HYPERTENSIVE RATS
Dahkki: Syme, P, et al.
Almmustuhtton: (1990)

In vivo cation transport during short-term and long-term digoxin therapy.
Dahkki: Boon, N, et al.
Almmustuhtton: (1986)

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1978)

Digoxin revisited.
Dahkki: Aronson, J
Almmustuhtton: (1998)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1977)

Cohesion and polymorphism in solid rubidium chloride
Dahkki: Pyper, N, et al.
Almmustuhtton: (2006)

The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.
Dahkki: Ford, A, et al.
Almmustuhtton: (1979)

Interaction of digoxin with quinine.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1981)

Clinical pharmacokinetics of digoxin 1980.
Dahkki: Aronson, J
Almmustuhtton: (1980)

DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE
Dahkki: Aronson, J, et al.
Almmustuhtton: (1983)

Indications for the measurement of plasma digoxin concentrations.
Dahkki: Aronson, J
Almmustuhtton: (1983)

ABC of monitoring drug therapy. Digoxin.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1992)

Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.
Dahkki: Ford, A, et al.
Almmustuhtton: (1979)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
Dahkki: Ford, A, et al.
Almmustuhtton: (1979)

Monitoring digoxin therapy: III. How useful are the nomograms?
Dahkki: Aronson, J
Almmustuhtton: (1978)

The use of colour vision measurement in the diagnosis of digoxin toxicity.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1980)

Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1977)

InVivo Therapeutics® Corporation
Dahkki: Reynolds, Francis M., M.B.A. Massachusetts Institute of Technology
Almmustuhtton: (2007)

STUDIES OF HUMAN ADIPOSE-TISSUE INVIVO
Dahkki: Frayn, K
Almmustuhtton: (1992)

An ultrasonic study of hydroxyl ion in single crystals of rubidium chloride / [mikrofilem]
Dahkki: 392541 Ho, Wai Kwong Bernard

Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.
Dahkki: Pugh, SE, et al.
Almmustuhtton: (1989)

CHYLOMICRONS ARE THE PREFERRED SUBSTRATE FOR LIPOPROTEIN-LIPASE INVIVO
Dahkki: Potts, J, et al.
Almmustuhtton: (1991)

CARBOHYDRATE-METABOLISM IN HUMAN ADIPOSE-TISSUE INVIVO
Dahkki: Coppack, S, et al.
Almmustuhtton: (1989)

Uniaxial tension test of human-skin invivo
Dahkki: Wan Abas, W.A.B., et al.
Almmustuhtton: (1982)

Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
Dahkki: Sophia Sheikh, et al.
Almmustuhtton: (2024-06-01)

INCREASED NA+-H+ ANTIPORT ACTIVITY INVIVO IN SKELETAL-MUSCLE OF SPONTANEOUSLY HYPERTENSIVE RATS CAN BE REVERSED BY NIFEDIPINE
Dahkki: Syme, P, et al.
Almmustuhtton: (1990)

Effects of Age, Gender, and Comorbid Diseases on Serum Digoxin Levels During Digoxin Treatment
Dahkki: Zeynep ÖZTÜRK, et al.
Almmustuhtton: (2018-01-01)

EVIDENCE FOR LACTATE PRODUCTION BY HUMAN ADIPOSE-TISSUE INVIVO
Dahkki: Frayn, K, et al.
Almmustuhtton: (1990)

Disposition of oral quinine in acute falciparum malaria.
Dahkki: Supanaranond, W, et al.
Almmustuhtton: (1991)

Anticariogenic Activity of Black Tea - An Invivo Study
Dahkki: Vishal Arya, et al.
Almmustuhtton: (2016-03-01)

Loading rubidium atoms into a hollow core fiber
Dahkki: Chu, Yiwen
Almmustuhtton: (2008)

MAX AND MYC/MAX COMPLEXES ACTIVATE TRANSCRIPTION INVIVO
Dahkki: Fisher, F, et al.
Almmustuhtton: (1993)